MGC Pharmaceuticals Ltd
ASX:MXC

Watchlist Manager
MGC Pharmaceuticals Ltd Logo
MGC Pharmaceuticals Ltd
ASX:MXC
Watchlist
Price: 0.415 AUD Market Closed
Market Cap: 18.2m AUD

Wall Street
Price Targets

MXC Price Targets Summary
MGC Pharmaceuticals Ltd

There are no price targets for MXC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
MGC Pharmaceuticals Ltd Competitors:
Price Targets
13
HUTCHMED (China) Ltd
58% Upside
HRMY
Harmony Biosciences Holdings Inc
16% Upside
195940
HK Inno.N Corp
26% Upside
XERS
Xeris Biopharma Holdings Inc
64% Upside
000756
Shandong Xinhua Pharmaceutical Co Ltd
30% Downside
086450
Dongkook Pharmaceutical Co Ltd
38% Upside
BMY
Bristol-Myers Squibb Co
2% Upside
ACB
Aurora Cannabis Inc
9% Upside

Revenue
Forecast

Revenue Estimate
MGC Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for MGC Pharmaceuticals Ltd's revenue is 121%. The projected CAGR for the next 2 years is 40%.

121%
Past Growth
40%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
MGC Pharmaceuticals Ltd

Operating Income forecast
is not available for
MGC Pharmaceuticals Ltd

Net Income
Forecast

Net Income Estimate
MGC Pharmaceuticals Ltd

Net Income forecast
is not available for
MGC Pharmaceuticals Ltd
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MXC's stock price target?
Not Available

MXC doesn't have any price targets made by Wall Street professionals.

What is MGC Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
40%

For the last 8 years the compound annual growth rate for MGC Pharmaceuticals Ltd's revenue is 121%. The projected CAGR for the next 2 years is 40%.

Back to Top